58. Substance Abuse: Cocaine Use Disorders
- Allan Tasman Professor Chair4,
- Jerald Kay Professor Chair5,
- Jeffrey A. Lieberman Lawrence Kolb Professor Chairman Director Psychiatrist in Chief6,7,8,
- Michael B. First Professor of Clinical Psychiatry6,7,9,
- Mario Maj Professor Chair10
Published Online: 8 AUG 2008
DOI: 10.1002/9780470515167.ch58
Copyright © 2008 John Wiley & Sons, Ltd
Book Title

Psychiatry, Third Edition
Additional Information
How to Cite
Baker, J. R., Jin, C. Y. and McCance-Katz, E. F. (2008) Substance Abuse: Cocaine Use Disorders, in Psychiatry, Third Edition (eds A. Tasman, J. Kay, J. A. Lieberman, M. B. First and M. Maj), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470515167.ch58
Editor Information
- 4
Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY, USA
- 5
Department of Psychiatry, Wright State University Boonshoft School of Medicine, Dayton, OH, USA
- 6
Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA
- 7
New York State Psychiatric Institute, New York, NY, USA
- 8
Columbia University Medical Center, New York – Presbyterian Hospital, New York, NY, USA
- 9
Department of Psychiatry, Columbia University Medical Center, New York, NY, USA
- 10
Department of Psychiatry, University of Naples, Naples, Italy
Publication History
- Published Online: 8 AUG 2008
- Published Print: 16 APR 2008
ISBN Information
Print ISBN: 9780470065716
Online ISBN: 9780470515167
- Summary
- Chapter
Keywords:
- cocaine abuse;
- cocaine dependence;
- substance abuse treatment;
- cocaine pharmacotherapy
Summary
Chapter 58, Substance Abuse Disorders: Cocaine Use Disorders, provides the reader with a review of the epidemiology, neurobiology, diagnosis of cocaine use disorders and cocaine- related disorders, and treatment of these disorders. The text emphasizes evidence-based psychosocial therapies for the treatment of cocaine use disorders and provides a review of research in the area of cocaine pharmacotherapy development.
